Zurich, Switzerland
Peripal AG, founded in 2015 and headquartered in Switzerland, is a promising player in the medical device sector, specifically targeting the home dialysis market. With the inventive PeriSafe® device, the company aims to revolutionize home dialysis by enhancing safety and ease of use for patients, especially the elderly.
Peripal AG's slogan, "bring patients home, where they belong," emphasizes its mission to empower patients to receive treatment in the comfort of their homes, thereby reducing healthcare costs. The device eliminates manual handling in dialysis, addressing critical patient feedback and usability concerns.
The market for home peritoneal dialysis, valued at $3.2 billion and growing at 6% annually, presents significant growth opportunities for Peripal AG. Having raised capital through a Series C round, backed by TR Invest AG, the company is well-positioned to capitalize on the increasing prevalence of chronic conditions like diabetes and hypertension, driving the demand for effective home healthcare solutions.
